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Acquired Hyperplastic Gastric Polyps After 
Treatment of Ulcer
Wen-Hsiung Chang, Shou-Chuan Shih, Horng-Yuan Wang, Ching-Wei Chang, 
Chih-Jen Chen, Ming-Jen Chen*
Background/Purpose: Healing of gastric ulcers requires repair by epithelial migration and proliferation. We
have found a small proportion of patients with acquired hyperplastic polyps at the healed ulcer site. The aim
of this study was to identify clinical characteristics that might be associated with the development of hyper-
plastic polyps at the site of healed gastric ulcers.
Methods: This was a retrospective review of 86 patients with gastric ulcers from April 2006 to September 2008.
After initial endoscopy, the patients were all treated with proton pomp inhibitors, after which a second en-
doscopy was performed. Demographic data, polyp characteristics (endoscopic and histological), Helicobacter
pylori status, and duration of treatment were analyzed.
Results: A total of 24 hyperplastic gastric polyps were found in 18 patients; all at the site of the healed ulcer
(20 in the antrum and 4 in the corpus). The mean size of the ulcers prior to treatment was 14.5 ± 9.1 mm.
Hyperplastic gastric polyps were more likely to occur at the site of ulcers larger than 10 mm (odds ratio = 9.57,
95% confidence interval = 2.50–36.65). Age, sex, H. pylori status, ulcer location and duration of treatment did
not differ significantly between patients with and without polyps.
Conclusion: Hyperplastic polyps that develop after healing of gastric ulcers are likely to be extensive mucosal
injury. A gastric ulcer larger than 10 mm is associated with a significantly increased risk of hyperplastic polyps.
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Ulcer healing requires interaction between vari-
ous tissues and cell types1 to achieve restoration of
normal mucosal architecture.2 This active process
is characterized by replacing the mucosal defect
by accelerated cell migration and proliferation,
which is supported by an important meshwork of
connective tissue components.3 This process also
requires close interaction between growth factors
such as epidermal growth factor, transforming
growth factor, and fibroblast growth factor,4,5 as
well as cytokine-mediated signals to propel cells
through the cell cycle or towards apoptosis.6
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Unlike polyps of the colon, gastric polyps are
relatively uncommon, with an incidence of less
than 2–3%. They can be non-neoplastic, such as
hyperplastic polyps, or neoplastic, such as adeno-
mas.7 Hyperplastic polyps are by far the most com-
mon histological type.8 They are usually less than
1 cm in length and are found primarily in the
antrum and body of the stomach.9 The pathogen-
esis of hyperplastic polyps is not well understood,
in contrast to gastric fundic gland polyps, which
tend to arise in otherwise normal gastric mucosa.10
Proton pump inhibitors (PPIs) are potent
suppressors of gastric acid production, and they
can also have a pH-independent effect on ulcer
healing.11 Healing of gastric ulcers generally oc-
curs within 8–12 weeks. We have noted the de-
velopment of hyperplastic polyps at the site of
healed gastric ulcers in a small proportion of pa-
tients treated with PPIs, but we have found little
information in the literature to describe the nat-
ural history of hyperplastic polyps after treatment
of gastric ulcers.12,13 We designed this study to
investigate factors that might predispose to the
development of hyperplastic polyps at the site of
healed gastric ulcers.
Methods
Patients
We retrospectively reviewed the records of 2442
patients who underwent endoscopy by the same
investigator (Dr M.J. Chen) at Mackay Memorial
Hospital from April 2006 to September 2008. A
total of 503 patients (20.6%) were diagnosed with
gastric ulcer and 86 of those patients had under-
gone two endoscopic evaluations; one before
and one after treatment. Of these 86 individuals,
18 were found to have gastric polyps at the site of
the healed ulcers. The remaining 68 patients had
healed ulcers but no polyps. After initial endoscopic
diagnosis of a gastric ulcer, all patients were treated
with  30 mg/day lansoprazole, with treatment con-
tinuing until the second endoscopy was performed.
Patients with Helicobacter pylori infection upon
initial endoscopy were treated with eradication
therapy that consisted of 60 mg/day lansoprazole,
2 g/day amoxicillin, and 2 g/day tinidazole for 
7 days at the beginning of the treatment period.
All patients provided standard written informed
consent as required by our institution for the endo-
scopic procedures, which included agreement for
biopsies during the procedure when appropriate.
Demographic data, endoscopic and
histological evaluation
Demographic data, duration of ulcer treatment,
endoscopic findings (including size, number, and
location of ulcers and polyps), and H. pylori status
were extracted from the medical records. The size
of ulcers and polyps had been recorded in the
endoscopy report, with measurements made by
open biopsy forceps. H. pylori infection was diag-
nosed on the basis of a positive rapid urease test
(CLO test; Kimberly–Clark, Draper, UT, USA), or
the finding of organisms by modified Giemsa stain
in biopsy specimens. Hyperplastic gastric polyps
were diagnosed by histopathological evaluation of
the biopsy specimen, which showed elongation,
twisting, and cystic dilatation of the foveolae. A
further biopsy specimen was taken from the sur-
rounding mucosa of hyperplastic polyps for his-
topathological comparison.
Endoscopic and histological follow-up of
hyperplastic polyps
A third endoscopy to follow the hyperplastic pol-
yps was performed in eight patients. The size and
pattern of polyps were reviewed by comparing
photographs from each endoscopy. At follow-up,
the polyp size was assessed as having changed
(> 10% smaller or larger) or not. Two investiga-
tors independently assessed each set of images.
Disagreements were resolved by joint discussion
to reach a consensus. Biopsies were repeated at
each subsequent endoscopy to ensure that the
polyps were indeed hyperplastic.
Statistical analysis
Age, sex, ulcer size and position, duration of
treatment, and H. pylori status were compared
between patients with and without hyperplastic
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polyps. The χ2 test was used to compare the two
groups in terms of sex, ulcer site (antrum or cor-
pus), ulcer size (with 10 mm as the cutoff point),
and H. pylori status. Age, ulcer size, and duration
of treatment were compared with Student’s t test.
Univariate and multivariate logistic regression
analysis were performed to determine factors as-
sociated with development of hyperplastic polyps.
Significance was accepted at p < 0.05. Data were
analyzed using SPSS version 15.0 (SPSS Inc.,
Chicago, IL, USA).
Results
Polyps characteristics
Among the 18 patients studied (10 men and 8
women, aged 31–81 years), there were 24 hyper-
plastic gastric polyps; 20 in the antrum and four
in the corpus (Table 1). The second endoscopy at
which polyps were discovered was performed at a
mean of 3.4 ± 0.9 months (2.3–4.3 months) after
the first, which was equivalent to the duration of
treatment. The mean polyp size was 12.5±7.8 mm
(4–23 mm). One patient acquired more than
one polyp at the site of a single ulcer (Figure 1)
and five patients had polyps at the site of multi-
ple ulcers (Figure 2). All polyps were found to 
be hyperplastic, and none had adenomatous or
malignant features.
Prevalence of H. pylori infection and ulcer
size and site
The age, sex, location of previous ulcers, and treat-
ment duration were similar in patients with and
without polyps (Table 2). The overall prevalence of
H. pylori infection was slightly higher in the polyp
group (77.8%, 14/18) than in the control group
(52.9%, 36/68), but the difference were not sta-
tistical significant (p = 0.06). Before treatment,
the ulcers were significantly larger in the patients
with polyps compared with the control group
(14.5±9.1 mm vs. 6.5±5.4 mm, p=0.01) On step-
wise logistic regression, the only factor found to
be significantly associated with an increased risk
of developing a polyp was having had an ulcer
> 10 mm (odds ratio = 9.03, 95% confidence inter-
val = 2.64–30.91, p < 0.01) (Table 3).
Table 1. Characteristics of 18 patients with
hyperplastic gastric polyps*
Characteristic
Sex, male (%) 55.6
Age (yr) 57.5 ± 12.8
Polyp site (n)
Antrum 20
Corpus 4
Size of polyp (mm) 12.5 ± 7.8 (4–23)
Single polyps (n) 12
Multiple polyps (n) 6
*Data presented as n, mean ± standard deviation or mean ±
standard deviation (range).
Figure 1. Endoscopic image from an 81-year-old woman with two hyperplastic polyps located at the site of a large
healed ulcer in the anterior antral wall.
Endoscopic and histological follow-up of
polyps
Of the 18 patients with polyps, eight underwent
further endoscopic follow-up after the polyps
were discovered. Follow-up endoscopy was carried
out after an interval of 3–6 months, for a mean
observation period of 17.1 months (range, 5–28
months). Five of the eight patients had H. pylori
infection at their initial examination, which was
successfully eradicated. However, gastric polyps
persisted in all eight patients (mean length =
15.4 ± 4.3 mm; range, 8–23 mm). In two patients,
the polyps decreased to less than 10% of their
initial length, and none of the polyps increased in
size. Biopsies were repeated in all eight patients,
and the polyps were all hyperplastic, without
adenomatous or malignant features.
Discussion
The reported incidence of gastric polyps is gradu-
ally increasing because of the widespread use of
endoscopic examinations. We have described a
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Table 2. Helicobacter pylori status and original ulcer characteristics in patients with and without hyperplastic
polyps*
Hyperplastic polyp (n = 18) Control (n = 68) p
Age (yr) 57.5 ± 12.8 53.6 ± 13.6 0.28
Sex, male 10 (55.6) 37 (54.4) 0.93
Helicobacter pylori infection 14 (77.8) 36 (52.9) 0.06
Ulcer site in antrum 14 (77.8) 42 (61.8) 0.21
Ulcer size ≥ 10 mm 14 (77.8) 19 (27.9) < 0.01
Ulcer size (mm) 14.5 ± 9.1 6.5 ± 5.4 0.01
Treatment duration (mo) 3.4 ± 0.9 3.3 ± 0.8 0.74
*Data presented as n (%) or mean ± standard deviation.
Table 3. Multiple logistic regression analysis of
factors related to development of
hyperplastic gastric polyps at the site 
of healed gastric ulcers
Risk factor OR (95% CI) p
Age 1.02 (0.98–1.06) 0.28
Sex, male 1.05 (0.37–2.98) 0.93
Helicobacter pylori 3.11 (0.93–10.42) 0.06
infection
Ulcer site in antrum 2.17 (0.64–7.30) 0.21
Ulcer size ≥ 10 mm 9.03 (2.64–30.91) < 0.01
Treatment duration 1.13 (0.56–2.25) 0.74
OR = Odds ratio; CI = confidence interval.
Figure 2. Endoscopic image from a 69-year-old woman with acquired two hyperplastic polyps; she had previously had
three gastric ulcers.
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series of patients who acquired hyperplastic gas-
tric polyps in the 3–4 month interval between an
initial endoscopic diagnosis of gastric ulcer and 
a follow-up examination to ensure ulcer healing. 
Hyperplastic gastric polyps have been reported
after electrocoagulation of gastric antral vascular
ectasia with Nd:YAG (neodymium-doped yttrium
aluminium garnet) laser or argon plasma coagu-
lation.14 They have also been noted on the gastric
stoma side after Billroth I and II anastomoses.15
These stomal polyps might result from the reflux
of enteric contents into the remnant stomach.
The development of hyperplastic gastric polyps
after organ transplantation has been tentatively
attributed to altered immune responses associ-
ated with immunosuppressive therapy.16,17 Our
demonstration of hyperplastic polyps growing at
the site of healed gastric ulcers could shed further
light on the pathophysiology and predisposing
factors of such polyps.
Our patients with polyps had larger and deeper
ulcers than the control group of patients with
healed gastric ulcers but who did not develop
polyps. A gastric ulcer >10 mm was associated with
a significantly increased risk of hyperplastic pol-
yps. In fact, this was the only feature on multiple
regression analysis that significantly differentiated
those with and without polyps. Some authors have
hypothesized that the loose connective tissue of
the deeper muscularis propria serves as a reservoir
for resting fibroblasts or myofibroblasts.3 When
stimulated by mucosal injury, these cells differ-
entiate, proliferate, and migrate towards the ulcer
base. Their function is to synthesize extracellular
matrix and participate in mucosal repair. Hyper-
plastic polyps thus might be the result of over-
vigorous regeneration that would be more likely
to occur in response to the more severe injury
caused by large, deep ulcers that penetrate the
deeper muscularis propria.
Of the 18 patients with polyps, eight underwent
a third endoscopic follow-up after the polyps were
discovered at the second evaluation. Gastric polyps
persisted in all eight patients; the polyps decreased
to less than 10% of their initial length in two pa-
tients; and none of the polyps had grown larger.
The most commonly used approach to obtain ac-
curate endoscopic measurements is to introduce
an object that closes the lesion and then compare
the size of the object and the lesion. Rulers or open
biopsy forceps of known size have all been widely
used for this purpose. Using an object for reference
can minimize the zoom-in and zoom-out effect of
imaging that could interfere with the measurement.
In addition, there can be substantial variation in
size determinations noted between endoscopists.
In our study, all the endoscopic evaluations and
consecutive measurements were made by the same
endoscopist. This could have overcome, at least par-
tially, the subjectivity and poor reproducibility of
endoscopic measurements.
Overall H. pylori infection was more frequent in
patients with polyps (14/18) than in the control
group (36/68). Although this difference did not
achieve statistical significance, it is possible that
the small numbers in our series resulted in a type
II statistical error. H. pylori-induced damage to
the gastric mucosa triggers an inflammatory re-
sponse with a number of characteristics that might
influence ulcer healing. The response includes
stimulation of cell proliferation, increased ex-
pression of growth factors such as nuclear factor-
κB, and inhibition of apoptosis; all factors that
might inhibit healing.18 The gastrin produced in
H. pylori-infected antral mucosa might increase
cyclooxygenase-2 and prostaglandin production,
which is a host response that might actually con-
tribute to ulcer healing.19
A review of randomized controlled trials has
suggested that PPIs can heal gastric ulcers in 80–
90% of patients at 8 weeks.20 However, it has also
been suggested that PPIs should be prescribed for
longer when the ulcers are large, fibrosed, or unre-
sponsive to treatment.21 In our practice, we pre-
scribe PPIs for more than 8 weeks to ensure
complete healing of gastric ulcers. In our study,
the mean duration of treatment in the polyp and
control groups was 3.4 months, and all gastric
ulcers in both groups were completely healed.
Ji et al prospectively studied the effect of H. py-
lori eradication on hyperplastic polyps. In the 
H. pylori treatment arm, 15 of 22 patients had
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572 J Formos Med Assoc | 2010 • Vol 109 • No 8
disappearance of the polyps, whereas the polyps
persisted in all 21 untreated control patients.22 In
a retrospective study of 43 patients with hyper-
plastic polyps and H. pylori infection, Ohkusa et al
found that the polyps disappeared in 33 patients
after H. pylori eradication but persisted in 10.23
They stated that the polyps that persisted tended
to be larger, but these patients also had persi-
stently higher gastrin levels than those whose
polyps disappeared. Despite H. pylori eradication
in our study, none of the polyps disappeared in
the eight patients who were examined for a third
time. Why our results differed from the other 
two studies cited is unclear. In those studies, the
polyps were found incidentally and were not as-
sociated with ulcers, in contrast to our patients’
polyps that all developed at the site of healed
gastric ulcers. Also, the polyps in our study were
larger than those investigated by Ji and colleagues
(mean = 14.5 mm vs. 6.6 mm).
Abraham et al evaluated the surrounding gas-
tric mucosa of hyperplastic polyps in 160 pati-
ents.10 They found that 85% of the patients had
inflammatory mucosal pathology (including ac-
tive chronic gastritis and atrophic gastritis), and
focal intestinal metaplasia was found in 37% of
patients. In our study, 10 of 18 patients (56%) had
active chronic gastritis and one (5.6%) had focal
intestinal metaplasia. These results suggest an as-
sociation between various forms of gastritis and
the development of hyperplastic polyps.
Neither age nor sex differed among our 18 pa-
tients with polyps and the 68 without polyps. The
demographic characteristics thus cannot account
for the varying patterns of gastric ulcer, ulcer heal-
ing, and growth of hyperplastic polyps. It could be
that part of the answer lies in cytokine gene poly-
morphisms that result in varying gastric mucosal
response to injury and healing.
Nevertheless, our finding that hyperplastic pol-
yps are more likely to be associated with large gas-
tric ulcers and underlines the important role of
mucosal injury in the genesis of these polyps. We
believe that our study supports the view that hy-
perplastic polyps could be regenerative lesions that
arise at the site of previous severe mucosal injury.
We suspect that H. pylori infection might play a
role because of its association with disordered im-
mune responses, although we were not able to
demonstrate conclusively such an association in
our small series of patients. Further investigations
should focus on the coordinated interaction of all
structural layers of the gastric wall during gastric
ulcer healing, and mechanisms such as collagen
synthesis in the submucosa and muscularis pro-
pria, gastrin effects, and expression of growth fac-
tors in hyperplastic polyps.
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